COPENHAGEN, March 25 (Reuters) - Iceland will resume the use
of AstraZeneca's COVID-19 vaccine after suspending it on March
11 pending investigations into reports that it might be linked
to blood clots in some people who had been vaccinated, the
government said on Thursday.
A number of other European countries have also resumed use
of the vaccine after the European Medicines Agency confirmed
that it was safe to administer.
(Reporting by Jacob Gronholt-Pedersen)